Samuele Renzi

Quebec, QC G1V4G2, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Pediatric high-grade gliomas: Where do neurofibromatosis type one-associated high-grade gliomas stand in the landscape?

Pediatric high-grade gliomas: Where do neurofibromatosis type one-associated high-grade gliomas stand in the landscape?

Journal: Neuro-oncology practice

Published: October 28, 2025

Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.

Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas.

Journal: Nature communications

Published: October 09, 2025

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 07, 2025

TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.

TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.

Journal: Neuro-oncology

Published: October 01, 2025

Significant Response to Denosumab Yet with Severe Rebound Hypercalcemia in a 9-Year-Old Boy with Aneurysmal Bone Cyst: A Case Report.

Significant Response to Denosumab Yet with Severe Rebound Hypercalcemia in a 9-Year-Old Boy with Aneurysmal Bone Cyst: A Case Report.

Journal: Children (Basel, Switzerland)

Published: September 25, 2025

Combining anti-metabolic treatments with the repurposing of eribulin for glioblastoma: a clinical opportunity?

Combining anti-metabolic treatments with the repurposing of eribulin for glioblastoma: a clinical opportunity?

Journal: Translational cancer research

Published: September 08, 2025

Bevacizumab in Pediatric Neuro-Oncology.

Bevacizumab in Pediatric Neuro-Oncology.

Journal: Current oncology (Toronto, Ont.)

Published: August 31, 2025

Severe Hearing Loss in Children With Central Nervous System Tumors: A Population-Based Cancer in Young People in Canada (CYP-C) Report.

Severe Hearing Loss in Children With Central Nervous System Tumors: A Population-Based Cancer in Young People in Canada (CYP-C) Report.

Journal: Pediatric blood & cancer

Published: May 07, 2025

Ifosfamide-Related Optic Nerve Toxicity: Case Description and Review of the Literature.

Ifosfamide-Related Optic Nerve Toxicity: Case Description and Review of the Literature.

Journal: Pediatric blood & cancer

Published: April 15, 2025

Prenatal diagnosis and conservative management of a congenital cavernous sinus infantile hemangioma: illustrative case.

Prenatal diagnosis and conservative management of a congenital cavernous sinus infantile hemangioma: illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: April 14, 2025

Precision Medicine for Pediatric Glioma and NF1-Associated Tumors: The Role of Small Molecule Inhibitors.

Precision Medicine for Pediatric Glioma and NF1-Associated Tumors: The Role of Small Molecule Inhibitors.

Journal: Current oncology (Toronto, Ont.)

Published: April 14, 2025

Adjuvant Etoposide for Very High-risk PFA Ependymoma: A Case Report.

Adjuvant Etoposide for Very High-risk PFA Ependymoma: A Case Report.

Journal: Journal of pediatric hematology/oncology

Published: March 06, 2025

Showing 1-12 of 57

Last Updated: 09/26/2026